Bill Search

  • Introduced
    Mar 16, 2020
  • Passed Senate
  • Passed Assembly
  • Signed into Law
Did you know we offer free bill tracking in Congress and 50 states, and a great mobile app? Sign up here
S 2035
New Jersey Senate Bill
Requires public members of Drug Utilization Review Board to disclose financial interests and benefits received from and investment interests held in pharmaceutical distributors, pharmaceutical manufacturers, or pharmacy benefits managers.*
Last Action
Senate • Jun 03, 2021: Substituted by A277 (1R)
Latest bill text
Do you support this bill?
Yay Nay

Official Summary/Bill Text

Comments on Bill

Tweets

Whip Lists

Sponsors:
Actions
  • Jun 03, 2021 | Senate
    • Substituted by A277 (1R)
  • Feb 09, 2021 | Senate
    • Reported from Senate Committee with Amendments, 2nd Reading
  • Mar 16, 2020 | Senate
    • Introduced in the Senate, Referred to Senate Health, Human Services and Senior Citizens Committee
Documents